Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased to $0.18 in the quarter versus EPS of $-0.12 in the year-earlier quarter. Revenue Rose 213.47% to $68.9 million from the year-earlier quarter.
Arena Pharmaceuticals, Inc. reported adjusted EPS income of $0.18 per share. By that measure, the company beat the mean analyst estimate of $0.15. It beat the average revenue estimate of $57.31 million.